Integrative Management of Acute Diarrhoea: A Narrative Review of Modern Pharmacotherapy and Arogyavardhini Vati in Restoring Digestive Physiology is an open-access, peer-reviewed research paper by Janhavi G. Puri; Krishna N. Kadam; Rachnil R. Kamavisdar, published in Volume 15, Issue 10 of the International Journal of Advanced Research in Science and Technology (IJARST), a UGC-approved journal (Print ISSN 2319-1783, Online ISSN 2320-1126).
Janhavi G. Puri; Krishna N. Kadam; Rachnil R. Kamavisdar
Acute diarrhoea is a common illness that is usually infective but may also follow dietary, toxic or drug-related insults. Modern management centres on rehydration, with antimotility, antisecretory or antisecretory drugs chosen according to the clinical picture, and these control symptoms quickly. Many patients nevertheless report poor appetite, weak digestion, bloating and fatigue after the loose stools stop. Ayurveda describes the illness as Atisara and attributes delayed recovery to weakened Agni, accumulation of Ama and disturbed Grahani function. This narrative review sets the biomedical and Ayurvedic accounts of acute diarrhoea side by side, summarizes the mechanisms and positions of loperamide, racecadotril and the combination of ofloxacin and ornidazole, and examines the rationale for using Arogyavardhini Vati in the recovery phase. Sources were international guidelines, standard textbooks, classical Ayurvedic texts and indexed literature. The drugs act on motility, secretion and infection respectively and are not a fixed regimen. Arogyavardhini Vati is classically described as Deepana, Pachana, Yakritottejaka, supportive of Grahani and Rasayana, actions that correspond conceptually to appetite, digestion, bile flow, bowel rhythm and strength. It is not a classical indication for Atisara, controlled clinical evidence in this setting is lacking, and its metal-containing composition calls for quality assurance and qualified supervision. A sequential model in which modern medicine controls the disease and Ayurvedic measures support restoration of physiology is plausible, but requires well-designed trials before it can be recommended in routine care.
Keywords: acute diarrhoea; Atisara; Arogyavardhini Vati; Agni; Grahani; integrative medicine
DOI: https://doi.org/10.62226/ijarst20262846
References
1 World Health Organization. The Treatment of Diarrhoea: A Manual for Physicians and Other Senior Health Workers. 4th rev. Geneva: World Health Organization; 2005.
2 Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016;111(5):602-622.
3 Farthing M, Salam MT, Lindberg G, et al. Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol. 2013;47(1):12-20.
4 Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill; 2022.
5 GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1211-1228.
6 Munos MK, Walker CLF, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol. 2010;39(Suppl 1):i75-i87.
7 Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2016;12:CD005436.
8 Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65(12):e45-e80.
9 Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152(5):1042-1054.
10 Barbara G, Grover M, Bercik P, et al. Rome Foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019;156(1):46-58.
11 Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4554-4561.
12 Sharma RK, Dash B, translators. Agnivesha's Charaka Samhita (Text with English Translation and Critical Exposition Based on Chakrapani Datta's Ayurveda Dipika): Chikitsa Sthana, Chapter 15 (Grahani Dosha Chikitsa) and Chapter 19 (Atisara Chikitsa). Varanasi: Chowkhamba Sanskrit Series Office; reprint edition.
13 Tripathi B. Charaka Samhita of Agnivesha, Chikitsa Sthana. Varanasi: Chaukhambha Sanskrit Pratishthan; reprint edition.
14 Shastri AD. Sushruta Samhita, Uttara Tantra, Chapter 40 (Atisara Pratishedha). Varanasi: Chaukhambha Sanskrit Sansthan; reprint edition.
15 Murthy KRS, translator. Vagbhata's Astanga Hridayam: Nidana Sthana and Chikitsa Sthana (chapters on Atisara and Grahani). Varanasi: Chowkhamba Krishnadas Academy; reprint edition.
16 Murthy KRS, translator. Madhava Nidanam (Roga Viniscaya) of Madhavakara, Chapter 3 (Atisara Nidana). Varanasi: Chaukhambha Orientalia; reprint edition.
17 Payyappallimana U, Venkatasubramanian P. Exploring Ayurvedic knowledge on food and health for providing innovative solutions to contemporary healthcare. Front Public Health. 2016;4:57.
18 Government of India, Ministry of Health and Family Welfare, Department of AYUSH. The Ayurvedic Formulary of India, Part I. 2nd revised English ed. New Delhi: Government of India; 2003.
19 Govinda Das Sen. Bhaishajya Ratnavali, Kushtha Rogadhikara. Mishra S, commentator. Varanasi: Chaukhambha Surbharati Prakashan; reprint edition.
20 Vagbhata. Rasa Ratna Samuccaya. Kulkarni DA, translator. New Delhi: Meharchand Lachhmandas Publications; 1998.
21 Thiagarajah JR, Donowitz M, Verkman AS. Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol. 2015;12(8):446-457.
22 Collinson S, Deans A, Padua-Zamora A, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020;12:CD003048.
23 Brunton LL, Knollmann BC, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th ed. New York: McGraw-Hill; 2023.
24 Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med. 2007;4(3):e98.
25 Matheson AJ, Noble S. Racecadotril. Drugs. 2000;59(4):829-835.
26 Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med. 2000;343(7):463-467.
27 Lehert P, Cheron G, Calatayud GA, et al. Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis. Dig Liver Dis. 2011;43(9):707-713.
28 Hooper DC, Jacoby GA. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(9):a025320.
29 Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50(Suppl 1):S16-S23.
30 Sharma PV. Dravyaguna Vijnana, Vol. II (Vegetable Drugs). Varanasi: Chaukhambha Bharati Academy; reprint edition.
31 Saper RB, Kales SN, Paquin J, et al. Heavy metal content of Ayurvedic herbal medicine products. JAMA. 2004;292(23):2868-2873.
32 Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-923.
33 Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-924.
10.62226/ijarst20262846
PAGES : 178-183 | 6 VIEWS | 3 DOWNLOADS
Janhavi G. Puri; Krishna N. Kadam; Rachnil R. Kamavisdar — “Integrative Management of Acute Diarrhoea: A Narrative Review of Modern Pharmacotherapy and Arogyavardhini Vati in Restoring Digestive Physiology.” International Journal of Advanced Research in Science and Technology (IJARST), Volume 15, Issue 10. DOI: 10.62226/ijarst20262846.
Janhavi G. Puri; Krishna N. Kadam; Rachnil R. Kamavisdar | Integrative Management of Acute Diarrhoea: A Narrative Review of Modern Pharmacotherapy and Arogyavardhini Vati in Restoring Digestive Physiology | DOI : 10.62226/ijarst20262846
| Journal Frequency: | ISSN 2320-1126, Monthly | |
| Paper Submission: | Throughout the month | |
| Acceptance Notification: | Within 6 days | |
| Subject Areas: | Engineering, Science & Technology | |
| Publishing Model: | Open Access | |
| Publication Fee: | USD 60 USD 50 | |
| Publication Impact Factor: | 6.76 | |
| Certificate Delivery: | Digital |